Vor Biopharma Company
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Technology:
Drug Delivery, Stem cell therapy
Industry:
Gene therapy, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2016-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
9
Total Funding:
267800000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-12-07
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership